Urology Doctors in Wynnewood, PA Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Dr. Jennifer Beth Sherwood, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, 361 Lankenau Medical Building East, Wynnewood, PA 19096 Phone: 610-649-6420    Fax: 610-649-4689

Robert I Schnall, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, 361 Lankenau Medical Building East, Wynnewood, PA 19096 Phone: 610-649-6420    Fax: 610-649-4689

Michael J Hagg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, 361 Lankenau Medical Building East, Wynnewood, PA 19096 Phone: 610-649-6420    Fax: 610-649-4689

Dr. Max Ahn, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, 361 Lankenau Medical Office Building East, Wynnewood, PA 19096 Phone: 610-649-6420    Fax: 610-649-4689

Darlene Michelle Gaynor Krupnick, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave Ste 361, Wynnewood, PA 19096 Phone: 610-649-6420    Fax: 610-649-4689

News Archive

Disease-in-a-dish models show promise for treating ataxia telangiectasia

Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia.

Emmaus reports preliminary top-line results from Phase 3 clinical trial for treatment of sickle cell disease

Emmaus Life Sciences, Inc., a biopharmaceutical company dedicated primarily to the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases, today announced that preliminary top-line results of its Phase 3 clinical trial evaluating the safety and efficacy of its treatment for sickle cell anemia and sickle beta-0 thalassemia met both the primary and secondary endpoints of the clinical trial.

Ethicon unveils three new devices at IFSO 2014 to address unique challenges of bariatric procedures

Ethicon is introducing three new endocutter and energy products designed to help address the unique challenges of bariatric procedures such as sleeve gastrectomy and gastric bypass.

Gene that could affect the progress of ALS discovered

Researchers from the Zuckerman Institute at Columbia University have successfully found a gene that could work towards accelerating the progression of ALS or amyotrophic lateral sclerosis. The study titled, "The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice," was published in the latest issue of the journal Neuron.

Immunovia announces lung cancer program expansion based on encouraging study results

Immunovia AB today announced that the results of the current study in lung cancer strongly supports an expansion into the next stage in the discovery process.

Read more Medical News

› Verified 8 days ago